Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
A former Pfizer executive and current biopharmaceutical consultant took aim this week at what she called the “poorly managed” 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
AbbVie will no longer offer voluntary 340B pricing on any of its orphan-designated drugs to rural referral centers (RRC), sole [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Although Massachusetts lawmakers left Beacon Hill this month without passing a long-stalled 340B contract pharmacy access bill, provider groups say [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
More than two-thirds of 340B contract pharmacies are associated with pharmacy benefit managers (PBMs) through either vertical integration or contractual [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Senate panel responsible for federal appropriations legislation overwhelmingly passed a bill last week that would increase funding for the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Missouri’s new 340B contract pharmacy access law is getting increased attention in state primary races just days before voters head [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Four more U.S. House Democrats recently signed on to co-sponsor a federal bill (H.R. 7635) that would bar drugmaker restrictions [...] …